Stream and listen to our webinar on biomarkers!
Filippo Andreetta, Senior Supervisor, In Vitro Pharmacology and Elena Vicentini, Senior Supervisor Immunoassays and Biopharmaceuticals discuss the importance of biomarkers.
Stream the webinar today!
This webinar presents an overview of the potential advantages of a biomarkers strategy in the context of drug discovery and development to deliver new medicines into the market.
Literature reports that the primary cause of failure in phase II is efficacy, which is due to the lack of high exposure of drug to the target. A translational biomarkers strategy can be employed in the late phase of drug discovery and development to drive the candidate selection with a high target exposure, confirm the mechanisms of action and finally support the design of clinical study.